547-SSE-301: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-refractory Status Epilepticus.

  • Wainwright, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/18/15 → 9/2/19

Funding

  • Sage Therapeutics